Cargando…

Dynamics of the Type I Interferon Response During Immunosuppressive Therapy in Rheumatoid Arthritis

Objective: The type I interferon (IFN) response in rheumatoid arthritis (RA) has been extensively studied in relation to therapy with biological DMARDs (bDMARDs). However, the effect of conventional synthetic (cs)DMARDs and glucocorticoids (GCs) on IFN response gene (IRG) expression remains largely...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Jong, Tamarah D., Snoek, Tanja, Mantel, Elise, van der Laken, Conny J., van Vollenhoven, Ronald F., Lems, Willem F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491736/ https://www.ncbi.nlm.nih.gov/pubmed/31068954 http://dx.doi.org/10.3389/fimmu.2019.00902

Ejemplares similares

Effect of prednisone on type I interferon signature in rheumatoid arthritis: consequences for response prediction to rituximab
por: de Jong, Tamarah D, et al.
Publicado: (2015)

The type I interferon signature in leukocyte subsets from peripheral blood of patients with early arthritis: a major contribution by granulocytes
por: de Jong, Tamarah D., et al.
Publicado: (2016)

Early prediction of treatment response in rheumatoid arthritis by quantitative macrophage PET
por: Verweij, Nicki, et al.
Publicado: (2022)

Folate Receptor Beta for Macrophage Imaging in Rheumatoid Arthritis
por: Steinz, Maarten M., et al.
Publicado: (2022)

A novel 3D spheroid model of rheumatoid arthritis synovial tissue incorporating fibroblasts, endothelial cells, and macrophages
por: Philippon, Eva M. L., et al.
Publicado: (2023)

Preclinical Autoimmune Disease: a Comparison of Rheumatoid Arthritis, Systemic Lupus Erythematosus, Multiple Sclerosis and Type 1 Diabetes
por: Frazzei, Giulia, et al.
Publicado: (2022)

Quantitative Assessment of Arthritis Activity in Rheumatoid Arthritis Patients Using [(11)C]DPA-713 Positron Emission Tomography
por: Yaqub, Maqsood, et al.
Publicado: (2020)

Advances in the treatment of rheumatoid arthritis
por: Vivar, Nancy, et al.
Publicado: (2014)

Cancer risks in rheumatoid arthritis patients who received immunosuppressive therapies: Will immunosuppressants work?
por: Zhang, Yuzhuo, et al.
Publicado: (2022)

Sex differences in rheumatoid arthritis: more than meets the eye...
por: van Vollenhoven, Ronald F
Publicado: (2009)

The interferon type I signature towards prediction of non-response to rituximab in rheumatoid arthritis patients
por: Raterman, Hennie G, et al.
Publicado: (2012)

Type I interferon response gene expression in established rheumatoid arthritis is not associated with clinical parameters
por: de Jong, Tamarah D., et al.
Publicado: (2016)

The folate receptor β as a macrophage-mediated imaging and therapeutic target in rheumatoid arthritis
por: Chandrupatla, Durga M. S. H., et al.
Publicado: (2018)

Recombinant interferon alpha 2b in rheumatoid arthritis: good antigen for rheumatoid arthritis antibodies
por: Ali Khan, Wahid
Publicado: (2018)

Arterial wall inflammation is increased in rheumatoid arthritis compared with osteoarthritis, as a marker of early atherosclerosis
por: Agca, Rabia, et al.
Publicado: (2021)

Sustained biologic-free and drug-free remission in rheumatoid arthritis, where are we now?
por: Nagy, György, et al.
Publicado: (2015)

Measurement of stiffness in patients with rheumatoid arthritis in low disease activity or remission: a systematic review
por: van Tuyl, Lilian HD, et al.
Publicado: (2014)

Type I Interferon Gene Response Is Increased in Early and Established Rheumatoid Arthritis and Correlates with Autoantibody Production
por: Castañeda-Delgado, Julio E., et al.
Publicado: (2017)

Antirheumatic drugs for cardiovascular disease prevention: the case for colchicine
por: Lems, Willem, et al.
Publicado: (2021)

Pharmacological Management of Osteoporosis in Rheumatoid Arthritis Patients: A Review of the Literature and Practical Guide
por: Raterman, Hennie G., et al.
Publicado: (2019)

Dynamics of Type I and Type II Interferon Signature Determines Responsiveness to Anti-TNF Therapy in Rheumatoid Arthritis
por: Iwasaki, Takeshi, et al.
Publicado: (2022)

Content validity of the Dutch Rheumatoid Arthritis Impact of Disease (RAID) score: results of focus group discussions in established rheumatoid arthritis patients and comparison with the International Classification of Functioning, Disability and Health core set for rheumatoid arthritis
por: ter Wee, Marieke M., et al.
Publicado: (2016)

Systematic Review: Targeted Molecular Imaging of Angiogenesis and Its Mediators in Rheumatoid Arthritis
por: Khodadust, Fatemeh, et al.
Publicado: (2022)

Immune dynamics in SARS-CoV-2 experienced immunosuppressed rheumatoid arthritis or multiple sclerosis patients vaccinated with mRNA-1273
por: Verstegen, Niels JM, et al.
Publicado: (2022)

Does denosumab not only prevent fractures, but also bone erosions in rheumatoid arthritis?
por: Marsman, Anneke F, et al.
Publicado: (2022)

Heat Shock Proteins Can Be Surrogate Autoantigens for Induction of Antigen Specific Therapeutic Tolerance in Rheumatoid Arthritis
por: van Eden, Willem, et al.
Publicado: (2019)

Heterogeneity of the Type I Interferon Signature in Rheumatoid Arthritis: A Potential Limitation for Its Use As a Clinical Biomarker
por: Rodríguez-Carrio, Javier, et al.
Publicado: (2018)

Moving towards personalized medicine in rheumatoid arthritis
por: de Jong, Tamarah D, et al.
Publicado: (2014)

Interferon-β for treatment of rheumatoid arthritis?
por: van Holten, Judith, et al.
Publicado: (2002)

Tumor-mediated immunosuppression and cytokine spreading affects the relation between EMT and PD-L1 status
por: Lems, Carlijn M., et al.
Publicado: (2023)

The Natural Agonist of Estrogen Receptor β Silibinin Plays an Immunosuppressive Role Representing a Potential Therapeutic Tool in Rheumatoid Arthritis
por: Dupuis, Maria Luisa, et al.
Publicado: (2018)

ImmunosuppressiveTherapies Differently Modulate Humoral- and T-Cell-Specific Responses to COVID-19 mRNA Vaccine in Rheumatoid Arthritis Patients
por: Picchianti-Diamanti, Andrea, et al.
Publicado: (2021)

Malignancy rates in patients with rheumatoid arthritis treated with tocilizumab
por: Rubbert-Roth, Andrea, et al.
Publicado: (2016)

Gender and the treatment of immune-mediated chronic inflammatory diseases: rheumatoid arthritis, inflammatory bowel disease and psoriasis: an observational study
por: Lesuis, Nienke, et al.
Publicado: (2012)

Rheumatoid Arthritis Patients With Circulating Extracellular Vesicles Positive for IgM Rheumatoid Factor Have Higher Disease Activity
por: Arntz, Onno J., et al.
Publicado: (2018)

Full dose, reduced dose or discontinuation of etanercept in rheumatoid arthritis
por: van Vollenhoven, Ronald F, et al.
Publicado: (2016)

Protective Role of the MER Tyrosine Kinase via Efferocytosis in Rheumatoid Arthritis Models
por: Waterborg, Claire E. J., et al.
Publicado: (2018)

Multidrug resistance proteins and DMARD efficacy in rheumatoid arthritis
por: Jansen, G, et al.
Publicado: (2004)

Sustained Macrophage Infiltration upon Multiple Intra-Articular Injections: An Improved Rat Model of Rheumatoid Arthritis for PET Guided Therapy Evaluation
por: Chandrupatla, Durga M. S. H., et al.
Publicado: (2015)

In rheumatoid arthritis inflamed joints share dominant patient-specific B-cell clones
por: Musters, Anne, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pp073b72gq9vsdjlgvgs7avi0r